Published in Br J Cancer on December 15, 2003
Magnetic resonance-guided focused ultrasound surgery: Part 2: A review of current and future applications. Neurosurgery (2012) 1.53
Focused ultrasound surgery in oncology: overview and principles. Radiology (2011) 1.51
Progress and problems in the application of focused ultrasound for blood-brain barrier disruption. Ultrasonics (2008) 1.42
The potential of terahertz imaging for cancer diagnosis: A review of investigations to date. Quant Imaging Med Surg (2012) 1.26
Image-guided focused ultrasound ablation of breast cancer: current status, challenges, and future directions. Eur Radiol (2008) 1.19
Organ-sparing approaches for testicular masses. Nat Rev Urol (2010) 1.12
Quantitative ultrasound backscatter for pulsed cavitational ultrasound therapy- histotripsy. IEEE Trans Ultrason Ferroelectr Freq Control (2009) 1.08
MRI-guided high-intensity focused ultrasound ablation of bone: evaluation of acute findings with MR and CT imaging in a swine model. J Magn Reson Imaging (2013) 0.93
The effect of high intensity focused ultrasound treatment on metastases in a murine melanoma model. Biochem Biophys Res Commun (2008) 0.92
Perspectives of breast cancer thermotherapies. J Cancer (2014) 0.91
Minimally invasive ablative therapies for invasive breast carcinomas: an overview of current literature. World J Surg (2007) 0.90
Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound. World J Gastroenterol (2010) 0.88
Cavitation-enhanced MR-guided focused ultrasound ablation of rabbit tumors in vivo using phase shift nanoemulsions. Phys Med Biol (2014) 0.85
Accumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivo. J Healthc Eng (2013) 0.84
Image and pathological changes after radiofrequency ablation of invasive breast cancer: a pilot study of nonsurgical therapy of early breast cancer. World J Surg (2013) 0.83
Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancer. Chin J Cancer (2012) 0.82
Clinical Application of High-intensity Focused Ultrasound in Cancer Therapy. J Cancer (2016) 0.81
Magnetic resonance imaging: a potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancer. Int J Hyperthermia (2010) 0.81
Assessment of high-intensity focused ultrasound treatment of rodent mammary tumors using ultrasound backscatter coefficients. J Acoust Soc Am (2013) 0.80
High-intensity focused ultrasound for the treatment of fibroadenomata (HIFU-F) study. J Ther Ultrasound (2015) 0.78
Potential and problems in ultrasound-responsive drug delivery systems. Int J Nanomedicine (2013) 0.77
Cryosurgery in the treatment of women with breast cancer-a review. Gland Surg (2014) 0.77
Improved visualization of high-intensity focused ultrasound lesions. Ultrasound Med Biol (2006) 0.77
High-intensity focused ultrasound compared with irradiation for ovarian castration in premenopausal females with hormone receptor-positive breast cancer after radical mastectomy. Oncol Lett (2012) 0.76
High-Intensity Focused Ultrasound: Current Status for Image-Guided Therapy. Semin Intervent Radiol (2015) 0.76
Effective strategy of the combination of high-intensity focused ultrasound and transarterial chemoembolization for improving outcome of unresectable and metastatic hepatoblastoma: a retrospective cohort study. Transl Oncol (2014) 0.76
Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer. Cancer Immunol Immunother (2011) 0.75
A review of ablative techniques in the treatment of breast fibroadenomata. J Ther Ultrasound (2016) 0.75
Tumor characterization and treatment monitoring of postsurgical human breast specimens using harmonic motion imaging (HMI). Breast Cancer Res (2016) 0.75
Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With in vivo Two-Photon Microscopy. Theranostics (2017) 0.75
Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRI. PLoS One (2017) 0.75
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ (2000) 5.64
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1995) 5.27
Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med (1993) 3.54
Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med (1995) 3.43
MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology (2001) 2.54
Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol (2001) 1.78
Cryosurgery of breast cancer. Arch Surg (1997) 1.71
A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res (2001) 1.66
Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med Biol (2002) 1.46
Treatment of localised prostate cancer with transrectal high intensity focused ultrasound. Eur J Ultrasound (1999) 1.23
Histological changes in rat liver tumours treated with high-intensity focused ultrasound. Ultrasound Med Biol (1993) 1.04
Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology (2002) 1.04
Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. J Urol (1999) 1.04
Ablation of superficial bladder tumors with focused extracorporeal pyrotherapy. Urology (1996) 1.03
Extracorporeal high-intensity focused ultrasound for VX2 liver tumors in the rabbit. Hepatology (1995) 1.00
Characterization of extracorporeal ablation of normal and tumor-bearing liver tissue by high intensity focused ultrasound. Ultrasound Med Biol (1993) 0.98
Interstitial laser hyperthermia model development for minimally invasive therapy of breast carcinoma. J Am Coll Surg (1998) 0.95
Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog. Eur Urol (1992) 0.95
Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology (1999) 0.91
Targeted damage effects of high intensity focused ultrasound (HIFU) on liver tissues of Guizhou Province miniswine. Ultrason Sonochem (1997) 0.89
MRI study of hepatic tumours following high intensity focused ultrasound surgery. Br J Radiol (1997) 0.88
Saline-enhanced radiofrequency ablation of breast tissue: an in vitro feasibility study. Invest Radiol (2000) 0.88
Radio-frequency electrocautery ablation of mammary tissue in swine. Radiology (2000) 0.83
Stereotactically guided laser therapy of occult breast tumors: work-in-progress report. Arch Surg (2000) 0.82
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (1998) 16.08
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature (2000) 13.45
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science (1997) 11.89
Wild-type p53 activates transcription in vitro. Nature (1992) 11.39
Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci U S A (2001) 9.40
Genetic inheritance of gene expression in human cell lines. Am J Hum Genet (2004) 8.97
Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell (1993) 7.16
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell (2000) 6.69
Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell (1994) 5.25
Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet (1998) 4.67
Synapse-specific, long-term facilitation of aplysia sensory to motor synapses: a function for local protein synthesis in memory storage. Cell (1997) 3.93
Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann Intern Med (2001) 3.80
Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell (1998) 3.62
Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol (2001) 3.50
Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J (1991) 3.29
Human magnetic resonance imaging at 8 T. NMR Biomed (1998) 2.96
Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet (2002) 2.90
Effect of RF coil excitation on field inhomogeneity at ultra high fields: a field optimized TEM resonator. Magn Reson Imaging (2001) 2.84
IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat Immunol (2001) 2.81
A transient, neuron-wide form of CREB-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis. Cell (1999) 2.77
IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol (1999) 2.68
A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res (1999) 2.67
The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell (2001) 2.53
MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia. Neuron (1997) 2.50
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations. Leukemia (2007) 2.49
Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J (1996) 2.46
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med (2000) 2.44
An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature (1997) 2.42
Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A (2001) 2.40
Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene (1999) 2.34
Transcriptional regulation during cardiac growth and development. Annu Rev Physiol (1993) 2.33
The impact of California Proposition 99, a major anti-smoking law, on cigarette consumption. J Public Health Policy (1994) 2.27
Nitric-oxide dioxygenase activity and function of flavohemoglobins. sensitivity to nitric oxide and carbon monoxide inhibition. J Biol Chem (2000) 2.13
Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol (1998) 2.10
Kinetics of synaptotagmin responses to Ca2+ and assembly with the core SNARE complex onto membranes. Neuron (1999) 2.10
Premedication with intravenous dexmedetomidine-midazolam suppresses fentanyl-induced cough. Ir J Med Sci (2012) 2.06
Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem (2000) 2.05
Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J Biol Chem (1996) 2.05
Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet (2003) 2.03
Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem (1998) 1.99
Beta-COP is essential for transport of protein from the endoplasmic reticulum to the Golgi in vitro. J Cell Biol (1993) 1.88
Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem (1997) 1.86
Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci U S A (1997) 1.85
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.82
CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem (2000) 1.79
Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol (2001) 1.78
Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys (2000) 1.74
Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics. Clin Pharmacol Ther (2010) 1.74
CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem (2000) 1.72
The transmembrane protein Off-track associates with Plexins and functions downstream of Semaphorin signaling during axon guidance. Neuron (2001) 1.68
A novel role for RIP1 kinase in mediating TNFα production. Cell Death Dis (2012) 1.67
Morphological instability in InAs/GaSb superlattices due to interfacial bonds. Phys Rev Lett (2005) 1.61
A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression. Mol Cell Biol (1992) 1.61
Cloning and functional identification of a neuronal glutamine transporter. J Biol Chem (2000) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer (2009) 1.60
APC2 Cullin protein and APC11 RING protein comprise the minimal ubiquitin ligase module of the anaphase-promoting complex. Mol Biol Cell (2001) 1.59
Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J Biol Chem (1996) 1.57
Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ (2004) 1.54
A mathematical model for assessing control strategies against West Nile virus. Bull Math Biol (2005) 1.52
Design and assembly of an 8 tesla whole-body MR scanner. J Comput Assist Tomogr (1999) 1.52
The exogenous form of Jaagsiekte retrovirus is specifically associated with a contagious lung cancer of sheep. J Virol (1996) 1.51
The tandem C2 domains of synaptotagmin contain redundant Ca2+ binding sites that cooperate to engage t-SNAREs and trigger exocytosis. J Cell Biol (2001) 1.48
A novel system A isoform mediating Na+/neutral amino acid cotransport. J Biol Chem (2000) 1.47
Caveolin expression and localization in human keratinocytes suggest a role in lamellar granule biogenesis. J Invest Dermatol (2003) 1.47
Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. Genes Dev (1993) 1.45
Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem (2001) 1.45
Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res (1994) 1.45
Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton (1999) 1.45
synaptotagmin mutants reveal essential functions for the C2B domain in Ca2+-triggered fusion and recycling of synaptic vesicles in vivo. J Neurosci (2001) 1.45
Quantification of condylar resorption in temporomandibular joint osteoarthritis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 1.45
CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med (2001) 1.44
DYX1C1 functions in neuronal migration in developing neocortex. Neuroscience (2006) 1.42
Predicting durability of a disease resistance gene based on an assessment of the fitness loss and epidemiological consequences of avirulence gene mutation. Proc Natl Acad Sci U S A (2000) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Pathogen fitness penalty as a predictor of durability of disease resistance genes. Annu Rev Phytopathol (2001) 1.41
RNA processing and expression of an intron-encoded protein in yeast mitochondria: role of a conserved dodecamer sequence. Mol Cell Biol (1987) 1.41
Left ventricular myocardial adenosine triphosphate changes during reperfusion of ventricular fibrillation: the influence of flow and epinephrine. Crit Care Med (2000) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ (1993) 1.36
Characterization of S-triazine herbicide metabolism by a Nocardioides sp. isolated from agricultural soils. Appl Environ Microbiol (2000) 1.35
Activation of caspase-2 in apoptosis. J Biol Chem (1997) 1.35
Biodistribution of monoclonal antibodies: scale-up from mouse to human using a physiologically based pharmacokinetic model. Cancer Res (1995) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating mice [correction of rat] liver. Hepatology (1999) 1.34
In vitro squelching of activated transcription by serum response factor: evidence for a common coactivator used by multiple transcriptional activators. Nucleic Acids Res (1992) 1.33
Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers. Lung Cancer (1998) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Transl Psychiatry (2011) 1.32
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Oxidative stress in spinal cord injury and antioxidant-based intervention. Spinal Cord (2011) 1.27
Characterization of an atrazine-degrading Pseudaminobacter sp. isolated from Canadian and French agricultural soils. Appl Environ Microbiol (2000) 1.27
Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer. Histopathology (2007) 1.27
Modulation of oncogenic potential by alternative gene use in human prostate cancer. Nat Med (1999) 1.26
Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli. Proc Natl Acad Sci U S A (2000) 1.26
Cognitive, cardiac, and physiological safety studies in ultra high field magnetic resonance imaging. Magn Reson Imaging (1999) 1.25